Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study

BMC Women's Health

Volumn 8, Issue , 2008, Pages

  Larsson, Per Göran ^a   Stray Pedersen, Babill ^b   Ryttig, Kjeld R ^c   Larsen, Stig ^d  

^a Kärnsjukhuset ^*  (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c Farmaservice   (Denmark)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CLINDAMYCIN; ECOVAG; FLUCONAZOLE; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ADJUVANT THERAPY; ADULT; ARTICLE; ASTHMA; BACTERIAL STRAIN; BRONCHITIS; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; HEMORRHOID; HUMAN; INFLUENZA; LACTOBACILLUS; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL CYCLE; NONHUMAN; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK ASSESSMENT; RISK REDUCTION; TREATMENT DURATION; URINARY TRACT INFECTION; VAGINITIS; WHIPLASH INJURY; CONFIDENCE INTERVAL; FOLLOW UP; INTRAVAGINAL DRUG ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NORWAY; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; RISK; VAGINA; WOMEN'S HEALTH;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTOBACILLUS; MIDDLE AGED; NORWAY; ODDS RATIO; PROBIOTICS; RECURRENCE; VAGINA; VAGINOSIS, BACTERIAL; WOMEN'S HEALTH;

EID: 39449099261     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-8-3     Document Type: Article

References (21)

1. Larsson PG Fahraeus L Carlsson B Jakobsson T Forsum U: Late miscarriage and preterm birth after treatment with clindamycin: A randomised consent design study according to Zelen. Bjog 2006, 113(6):629-637. 16709205
2. ACOG: Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, Number 72, May 2006: Vaginitis Obstet Gynecol 2006, 107(5):1195-1206. 16648432
3. Kane KY Pierce R What are the most effective treatments for bacterial vaginosis in nonpregnant women? J Fam Pract 2001 50 5 399 400 11350701
4. Joesoef MR Schmid G: Bacterial vaginosis. Clin Evid 2004, 11:2054-2063. 15652096
5. Larsson PG Forsum U: Bacterial vaginosis - a disturbed bacterial flora and treatment enigma. Apmis 2005, 113(5):305-316. 10.1111/ j.1600-0463.2005.apm_113501.x 16011656
6. Bradshaw CS Morton AN Hocking J Garland SM Morris MB Moss LM Horvath LB Kuzevska I Fairley CK: High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006, 193(11):1478-1486. 10.1086/503780 16652274
7. Forsum U Hallen A Larsson PG: Bacterial vaginosis - A laboratory and clinical diagnostics enigma. Apmis 2005, 113(3):153-161. 10.1111/ j.1600-0463.2005.apm1130301.x 15799757
8. Vasquez A Jakobsson T Ahrne S Forsum U Molin G: Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol 2002, 40(8):2746-2749. 120688 12149323 10.1128/JCM.40.8.2746-2749.2002
9. Hallen A Jarstrand C Pahlson C: Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis 1992, 19(3):146-148. 1523530
10. Reid G Charbonneau D Erb J Kochanowski B Beuerman D Poehner R Bruce AW: Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003, 35(2):131-134. 10.1016/S0928-8244(02)00465-0 12628548
11. Anukam K Osazuwa E Ahonkhai I Ngwu M Osemene G Bruce AW Reid G: Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, double-blind, placebo controlled trial. Microbes Infect 2006, 8(6):1450-1454. 10.1016/ j.micinf.2006.01.003 16697231
12. Eriksson K Carlsson B Forsum U Larsson PG: A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm Venereol 2005, 85(1):42-46. 10.1080/00015550410022249 15848990
13. Amsel R Totten PA Spiegel CA Chen K Eschenbach DA Holmes KK: Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983, 74:14-22. 10.1016/0002-9343(83)91112-9 6600371
14. Hay PE Lamont RF Taylor-Robinson D Morgan DJ Ison C Pearson J: Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. Bmj 1994, 308(6924):295-298. 8124116
15. Ison CA Hay PE: Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect 2002, 78(6):413-415. 10.1136/sti.78.6.413 12473800
16. Nugent RP Krohn MA Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991, 29(2):297-301. 269757 1706728
17. Kleinbaum DG: Survival Analysis A self-Learning Text New York: Springer-Verlag 2 1997
18. Sjöberg I Håkansson S Holm SE: Accumulation of penicillin in vaginal fluid. Obstet Gynecol 1990, 75:18-21. 2104967
19. Sobel JD Ferris D Schwebke J Nyirjesy P Wiesenfeld HC Peipert J Soper D Ohmit SE Hillier SL: Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006, 194(5):1283-1289. 10.1016/j.ajog.2005.11.041 16647911
20. Larsson PG Bergstrom M Forsum U Jacobsson B Strand A Wolner-Hanssen P: Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: An enigma. Apmis 2005, 113(4):233-245. 10.1111/ j.1600-0463.2005.apm_01.x 15865604
21. Larsson PG Carlsson B Fahraeus L Jakobsson T Forsum U: Diagnosis of bacterial vaginosis: Need for validation of microscopic image area used for scoring bacterial morphotypes. Sex Transm Infect 2004, 80(1):63-67. 10.1136/sti.2003.006106 14755040